1,329 calculators and references across 60 specialties, with formula confidence shown up front.
: Explanation and Clinical Context This tool estimates a woman’s 10-year risk of atherosclerotic cardiovascular disease (ASCVD), incorporating traditional risk factors such as age, blood pressure, lipid profile, and smoking status, with an additional adjustment for age at menopause. Early menopause (before 55 years) is independently associated with increased ASCVD risk due to prolonged estrogen deficiency. The algori
Metabolic Age Acceleration Index (CV Projection): Explanation and Clinical Context The Metabolic Age Acceleration Index (MAAI) is a composite measure designed to quantify cardiovascular risk in relation to metabolic aging. It integrates chronological age with clinical biomarkers including BMI, fasting glucose, systolic blood pressure, and total cholesterol, reflecting the biological acceleration of cardiovascular agi
: Explanation and Clinical Context The ATP III definition operationalizes metabolic syndrome (MetS) as a cluster of five components—central obesity, elevated triglycerides, reduced HDL cholesterol, elevated blood pressure, and elevated fasting plasma glucose—of which any three confer a diagnosis. The original ATP III report (2001) used fasting plasma glucose ≥110 mg/dL; in 2005, an AHA/NHLBI scientific statement alig
Metformin Cardio-Protection: Explanation and Clinical Context This calculator estimates the potential absolute cardiovascular risk reduction when adding or continuing metformin, by applying an assumed relative risk reduction (RRR) to a patient’s baseline cardiovascular event risk over a specified time horizon. It is intended for scenario planning rather than definitive prognostication because, to date, there is no un